Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q1LSK8

Entry ID Method Resolution Chain Position Source
AF-Q1LSK8-F1 Predicted AlphaFoldDB

No variants for Q1LSK8

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q1LSK8

No associated diseases with Q1LSK8

7 regional properties for Q1LSK8

Type Name Position InterPro Accession
domain Translational (tr)-type GTP-binding domain 379 - 548 IPR000795
domain Small GTP-binding protein domain 382 - 538 IPR005225
domain Translation initiation factor IF-2, N-terminal 1 - 52 IPR006847-1
domain Translation initiation factor IF-2, N-terminal 303 - 351 IPR006847-2
domain Initiation factor 2 associated domain, bacterial 57 - 92 IPR013575
domain Translation initiation factor IF- 2, domain 3 655 - 768 IPR023115
domain Translation initiation factor IF-2, domain II 555 - 648 IPR044145

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

3 GO annotations of molecular function

Name Definition
GTP binding Binding to GTP, guanosine triphosphate.
GTPase activity Catalysis of the reaction: GTP + H2O = GDP + H+ + phosphate.
translation initiation factor activity Functions in the initiation of ribosome-mediated translation of mRNA into a polypeptide.

No GO annotations of biological process

Name Definition
No GO annotations for biological process

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MKNVTVKSLA VEMQISVDHL VQQFSNVGFH KTARDYVTQQ EKETLLAYLK YELSNTPLTL
70 80 90 100 110 120
QRKTRSTLNI ASTSGRSKSV QVEVRKKHIY IQPVAHDSIL TIKENILPNN TQEVKNNAEA
130 140 150 160 170 180
SPKTKFILTP KQQSKIAKNN IVNNQNNLIK KSRQISEKAI LEAKAAELKH QAEEETRRKV
190 200 210 220 230 240
EEKARQIAEE ARQFAEHNDS IWMTTPELAE DDTIDDNLSN YHYASIVEDE NNRKIENERR
250 260 270 280 290 300
TRGNKVSKQK TYRLSEFKKN REEARAVGRS SKSQSKRKSS TLMQVFNKPS QVINRDIVIG
310 320 330 340 350 360
EMITVAELAN KMAVKGSQII KKLIQLGVMA TINQIIDRET AQLVAEDMGH KVILLRENEL
370 380 390 400 410 420
EESIMKDRKI DSSVDNAESR APVVTIMGHV DHGKTSLLDY IRSTKVVASE AGGITQHIGA
430 440 450 460 470 480
YHVETDRGMI TFLDTPGHAA FTAMRARGAR TTDIVVLVVA ADNGAMPQTI EAIQHAKAAK
490 500 510 520 530 540
VPIVVAVNKI DKKEANPENI KNELTKHGII PEEWGGQNQF VNISAKYGTG INNLLDAILL
550 560 570 580 590 600
QAEVLELKAI RNGIASGIVI ESFLDKGRGP VATILVREGT LHHGDMILCG LEYGRVRAMR
610 620 630 640 650 660
DEQGRHLSTA GPSVPVEILG LSGVPIAGDE AMVVRDEKKA REVALYRQGK FREGKLARKH
670 680 690 700 710 720
SAKLENMFTN ISEGGILELN IILKTDVQGS VEAINDALEQ LSTEKAKVKI IGSGVGGITE
730 740 750 760 770 780
TDATLAAASN AILIGFNVRA DASARRIIDK ENLNIHYYSV IYHLINEVTQ AMNGMLTPEY
790 800 810 820 830 840
KQDIIGLAEV RNVFSVPKFG LIAGCMVIEG IVKRHNNIRV IRNNIIIYEG ELYSLRRFKD
850 860 870
DVNEVRNGME CGIGVKNYTD IRTGDIIEVF KLIPIIKSSN